If you’re navigating MS care in Kentucky, you have several regional options from Louisville to Lexington and beyond. Consider how each center’s expertise, location, and provider availability fit your needs — for many patients, Norton Neuroscience Institute, UK Neurology MS and Neuroimmunology, and University of Louisville Neurology are important options to evaluate.
6 MS treatment centers9 active clinical trials10 providers with Medicare prescribing dataTop regional centers in Louisville and Lexington
Center types in Kentucky
Academic MS Center (3)
Regional Neurology Group (1)
Community Hospital Program (1)
Dedicated MS Practice (1)
Filter by type:
50% of MS centers in Kentucky are classified as Academic MS Center facilities.
Centers with Most Active Trials in Kentucky
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
Largest Care Teams in Kentucky
1. University of Louisville Neurology4 providers
3. UK Neurology MS and Neuroimmunology3 providers
MS Care by City
Active MS clinical trials in Kentucky
See all 12 MS trials in Kentucky →ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Nicholasville
ActivePhase 3
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Hoffmann-La Roche
Nicholasville
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Louisville
ActivePhase 3
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
Sanofi
Lexington · Louisville
Active
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Johns Hopkins University
Louisville
RecruitingPhase 1
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
National Cancer Institute (NCI)
Lexington
RecruitingPhase 3
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
Lexington · Louisville
Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
TG Therapeutics, Inc.
Lexington · Louisville





